CLAPS, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 4.285
AS - Asia 3.805
EU - Europa 2.863
SA - Sud America 664
AF - Africa 124
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.786
Nazione #
US - Stati Uniti d'America 4.090
SG - Singapore 1.451
CN - Cina 972
IT - Italia 834
BR - Brasile 496
HK - Hong Kong 491
SE - Svezia 425
DE - Germania 198
VN - Vietnam 189
RU - Federazione Russa 176
GB - Regno Unito 170
FR - Francia 160
NL - Olanda 151
PL - Polonia 146
KR - Corea 136
IN - India 123
CA - Canada 119
FI - Finlandia 89
TR - Turchia 89
IE - Irlanda 81
BG - Bulgaria 80
JP - Giappone 74
ES - Italia 67
AR - Argentina 65
CH - Svizzera 60
AT - Austria 51
MA - Marocco 45
MX - Messico 45
ID - Indonesia 38
BE - Belgio 37
IR - Iran 37
BD - Bangladesh 34
AU - Australia 33
CO - Colombia 31
PK - Pakistan 31
UA - Ucraina 27
TW - Taiwan 22
EC - Ecuador 21
RO - Romania 20
CL - Cile 17
ZA - Sudafrica 17
PH - Filippine 15
TN - Tunisia 15
CZ - Repubblica Ceca 14
MY - Malesia 14
IQ - Iraq 13
KE - Kenya 13
PT - Portogallo 13
EG - Egitto 12
JO - Giordania 10
LT - Lituania 10
VE - Venezuela 9
TH - Thailandia 8
HU - Ungheria 7
NP - Nepal 7
NZ - Nuova Zelanda 7
PE - Perù 7
UZ - Uzbekistan 7
BO - Bolivia 6
DK - Danimarca 6
IL - Israele 6
PY - Paraguay 6
SA - Arabia Saudita 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
GH - Ghana 5
GR - Grecia 5
HR - Croazia 5
NO - Norvegia 5
CR - Costa Rica 4
GE - Georgia 4
JM - Giamaica 4
KZ - Kazakistan 4
LV - Lettonia 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
ET - Etiopia 3
EU - Europa 3
KG - Kirghizistan 3
NI - Nicaragua 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BS - Bahamas 2
CI - Costa d'Avorio 2
EE - Estonia 2
GT - Guatemala 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
SI - Slovenia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 11.769
Città #
Singapore 794
Ashburn 497
Hong Kong 474
Chandler 332
Hefei 282
Beijing 229
Trieste 210
Fairfield 186
Los Angeles 161
Boardman 143
Chicago 123
Seoul 118
Ann Arbor 117
Princeton 114
Wilmington 113
Seattle 112
Columbus 101
Zgierz 96
Santa Clara 85
Houston 83
Woodbridge 82
Sofia 79
San Jose 75
Dublin 73
Ho Chi Minh City 73
Moscow 73
Cambridge 68
Milan 68
Dallas 61
São Paulo 60
Toronto 50
Bern 49
Helsinki 47
Frankfurt am Main 46
Jacksonville 46
Buffalo 45
London 45
The Dalles 45
Salt Lake City 42
Munich 41
New York 40
Rome 37
Elk Grove Village 36
Warsaw 36
Redwood City 35
Hanoi 34
Casablanca 33
Shanghai 33
Lappeenranta 31
Guangzhou 30
Vienna 30
Tokyo 29
Tampa 28
Brussels 27
Nuremberg 25
Redmond 24
Boston 23
Atlanta 21
San Diego 21
Palermo 20
Phoenix 20
Orem 19
Rio de Janeiro 19
Montreal 18
Tehran 18
Brooklyn 17
Chennai 17
North Bergen 17
Redondo Beach 17
Ankara 16
Bogotá 16
Denver 16
Istanbul 16
Norwalk 16
Sterling 16
Washington 16
Buenos Aires 15
Poplar 15
Pune 15
Düsseldorf 14
Lauterbourg 14
Paris 14
Lancaster 13
Madrid 13
Stockholm 13
Dong Ket 12
Hamilton 12
Manchester 12
Roubaix 12
Wroclaw 12
Cleveland 11
Dhaka 11
Hamburg 11
Izmir 11
Nairobi 11
Seville 11
Curitiba 10
Johannesburg 10
Lahore 10
Mexico City 10
Totale 6.697
Nome #
Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer 496
MtF sex reassignment surgery: Trombetta technique 422
Gender affirming surgery: Vaginoplasty and clitoroplasty with modified peno-scrotal flap technique 346
Preoperative impact of albumin to fibrinogen ratio (AFR) on oncological outcomes in patients with muscle invasive bladder cancer treated with radical cystectomy 250
Focal testicular lesions. Multiparametric us features and association with histopathology 242
Testis sparing surgery: Results of a large multicentric retrospective study 239
Utility of serum markers in the assessment of perioperative and postoperative morbidity and mortality after radical cystectomy 238
Warm ischemia time length during on-clamp partial nephrectomy: dose it really matter? 218
Testis Sparing Surgery of Small Testicular Masses: Retrospective Analysis of a Multicenter Cohort 204
Analysis of clinical utility of abdominopelvic computer tomography in the follow up of Stage I Seminoma. A single center evaluation 197
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients 169
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy 166
Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer 163
The role of preoperative controlling nutrtional status (CONUT) score in the assessment of pathological features and survival outcomes in clear-cell renal cell carcinoma (ccRCC): A population-based study 159
Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy 158
Learning Curve for Endoscopic Combined Intra-Renal Surgery Using Vacuum-Assisted Device 156
P-04-10 Italian Residents in Urology Sexual Health: A Multicentric Study 154
Reliable Prediction of Post-Operative Complications’ Rate Using the G8 Screening Tool: A Prospective Study on Elderly Patients Undergoing Surgery for Kidney Cancer 138
Impact of preoperative Controlling nutritional status (CONUT) score on perioperative morbidity and survival outcomes in patients with bladder cancer treated with radical cystectomy 137
An Observational Cohort Study Investigating the Incidence Rate of Infectious Complications After Routine Office Nephrostomy Tube Replacement Without Using Antimicrobial Prophylaxis 137
Rebiopsy rate after transperineal or transrectal prostate biopsy 136
MP80-05 TREND, CHARACTERISTICS AND IMPACT ON CANCER-SPECIFIC MORTALITY OF INCIDENTAL RENAL MASSES: RESULTS FROM A LARGE SERIES OF AUTOPSIES 135
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets 134
Impact of the COVID-19 pandemic on urology residency training in Italy 134
Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry 133
Analysis of clinical utility of abdominopelvic computer tomography in the surveillance of stage I seminoma. A single center evaluation 133
PD60-10 IMPACT OF PREOPERATIVE CONTROLLING NUTRITIONAL STATUS (CONUT) SCORE ON PERIOPERATIVE MORBIDITY AND SURVIVAL OUTCOMES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A MULTICENTER ANALYSIS 129
The role of preoperative cart score as predictor of renal functional decline after partial nephrectomy 128
External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study 125
Management of stuttering priapism 124
Optimization of the different therapeutic strategies in muscle invasive bladder cancer using biomarkers 124
Analysis of Bacterial Stent Colonization: The Role of Urine and Device Microbiological Cultures 122
Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy 121
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study 119
Improving pre-operative planning of robot assisted nephron sparing surgery using three-dimensional anatomical model 118
Infective complications after nephrostomy tube replacement without use of antimicrobical prophylaxis: A prospective study 118
Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility 116
Impact of antiplatlet or anticoagulation therapy in patients newly diagnosed bladder cancer: Preliminary results of a independent analysis of the Identify Study Italian cohort 115
Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy 115
Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration 114
Procalcitonin as prognostic factor in patients with Fournier's gangrene 113
The role of preoperative controlling nutritional status (CONUT) score in the assessment of survival outcomes in patients with muscle invasive bladder cancer (MIBC) treated with radical cystectomy: A pilot study 113
Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomy 112
Preliminary results from an independent analysis of the italian cohort of the identify study: Baseline features of italian patients investigated for suspicious urinary tract malignancy at 5 italian tertiary referral centers 112
Reliability of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: A precision study 110
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 110
The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer 107
Double-Layered Hand-Sewn versus Stapled Intestinal Anastomosis in Patients Who Underwent Ileal Urinary Diversion in Radical Cystectomy: A Comparative and Cost Effective Study 106
Time for a change in the management of small testicular masses: Results of a large multicentric retrospective study on testis sparing surgery 104
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program 102
Validation of the Italian version of wisconsin stone quality of life (WISQOL): a prospective Italian multicenter study 102
Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study 102
Artificial Intelligence in Bladder Cancer Diagnosis: Current Applications and Future Perspectives 101
Plication surgery does not produce additional loss of length in Peyronie’s disease patients 101
Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores 101
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis 100
Intraoperative laparoscopic ICG-guidance extended pelvic lymph node dissection in patients with intermediate and high-risk prostate cancer who underwent radical prostatectomy: A matched case-control study 99
Risk factors of bladder cancer in patients undergoing transurethral cystoscopy: A multicentric italian experience from the IDENTIFY study cohort 98
MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE 97
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study 96
External validation of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: a multicentric prospective study 95
Fluorescence Confocal Microscopy in Urological Malignancies: Current Applications and Future Perspectives 91
Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer 91
COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers 90
Smart learning for urology residents during the COVID-19 pandemic and beyond: insights from a nationwide survey in Italy 90
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 90
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 88
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum 87
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature 86
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival 86
MP46-17 INFECTIVE COMPLICATIONS AFTER NEPHROSTOMY TUBE REPLACEMENT WITHOUT USE OF ANTIMICROBICAL PROPHYLAXIS: A PROSPECTIVE STUDY 84
Arterioureteral fistula: An unusual cause of haematuria 10 years after the implantation of a synthetic iliac-femoral stent 83
Focus on the Use of Resveratrol in Bladder Cancer 82
Exploring the Residents’ Perspective on Smart learning Modalities and Contents for Virtual Urology Education: Lesson Learned During the COVID-19 Pandemic 82
Editorial Comment [to "Financial Toxicity After Robot-Assisted Radical Prostatectomy and Its Relation with Oncologic, Functional Outcomes"] 81
Idiopathic Retroperitoneal Fibrosis: What Is the Optimal Clinical Approach for Long-Term Preservation of Renal Function? 79
Reply by Authors 77
The IDENTIFY Study: The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicentre observational study 76
Targeted Prostate Biopsy: How, When, and Why? A Systematic Review 75
Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective study 75
The Added Value of Controlling Nutritional Status (Conut) Score for Preoperative Counselling on Significant Early Loss of Renal Function After Radical Nephrectomy for Renal Cell Carcinoma 74
Slowdown of urology residents’ learning curve during the COVID-19 emergency 73
The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series 72
Promising Biomarkers in Renal Cell Carcinoma 72
Novel Expanding Renal Cell Carcinoma Biomarkers 71
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 66
Frequency of testicular torsion presenting with abdominal pain in adults: a retrospective analysis of diagnostic and management implications 64
Laparoscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of indocyanine green: Results from a prospective study 64
MP25-12 PREDICTORS OF MAJOR COMPLICATIONS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: INSIGHTS FROM A RETROSPECTIVE MULTICENTRE REGISTRY 63
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy 60
Laroscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of Indocyanine Green: Results from a prospective study 60
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis? 59
Molecular markers of systemic therapy response in urothelial carcinoma 58
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy 56
Prostate cancer patients with lymphatic node involvement detected by immunohistochemistry. Is the effort worthwhile? 55
Novel Expanding Renal Cell Carcinoma Biomarkers 54
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 53
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer 53
Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomy 53
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding 52
Totale 11.888
Categoria #
all - tutte 43.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021468 0 0 0 0 0 0 175 61 28 80 41 83
2021/2022845 34 67 75 110 25 26 37 55 121 99 31 165
2022/20231.393 127 205 76 180 62 204 51 127 178 55 77 51
2023/20241.483 103 75 79 81 121 138 289 224 42 56 151 124
2024/20253.356 102 257 364 317 270 269 212 158 447 370 264 326
2025/20263.878 966 412 600 685 525 607 83 0 0 0 0 0
Totale 12.217